Relating to price transparency for prescription drugs sold in this state, and including applicability provisions

Where it is now

1. ✓
   Done: IntroducedFebruary 5, 2020
2. ✓
   Done: SubcommitteeFebruary 6, 2020
3. ✓
   Done: House committeeFebruary 19, 2020
4. ✕
   Stopped: Passes the HouseDied when the General Assembly ended
5. Next: Senate committee
6. Next: Passes the Senate
7. Next: To the Governor
8. Next: Signed into law

Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

House subcommittee

Named February 6, 2020. On February 12, 2020 it recommended passage.

• Rep. Shannon Lundgren REmail
• Rep. Jane Bloomingdale REmail
• Rep. John Forbes D

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Fiscal note

The resources required to implement the enforcement authority component of the Bill are difficult to estimate, as is the potential revenue generated from fines assessed under the provisions of the Bill. 0 FTE positions at the Insurance Company Examiner Specialist 2 and Compliance Officer 1 classifications would result in an annual estimated cost of $171,000.

• Prescription Drugs, Transparency · March 11, 2020

Nonpartisan cost estimates from the Legislative Services Agency’s Fiscal Services Division. The newest is first. Reading a fiscal note

Family tree

Where this legislation came from and where it went: earlier tries, the versions it moved through this Assembly, and later bills built on it.

Earlier and later bills are matched by wording or an identical title; check the text to be sure it’s the same idea.